JP Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities Inc., and other architects of bankrupted biotech company Zymergen Inc.'s market debut to pay $125M to settle investor class action
JP Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities Inc., and other architects of bankrupted biotech company Zymergen Inc.'s market debut to pay $125M to settle investor class action